Eton Pharmaceuticals, Inc. ( ETON) - Stock Earnings
ETON Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -1.9 million USD | 22.5 million USD |
| 2025Q4 | 1.5 million USD | 21.3 million USD |
| 2026Q1 | 1.6 million USD | 24.3 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ETON Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -936000 USD | 31.6 million USD |
| 2024 | -3.8 million USD | 39.0 million USD |
| 2025 | -4.6 million USD | 80.0 million USD |
| 2026 Est. | — | — |
ETON
Price: $29.28
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 36257
Market Capitalization: 756.3 million